| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 123.054 | 107.956 | 62.158 | 63.461 | 60.916 | 90.498 | 74.572 | 64.482 | 79.435 | 74.035 |
| Total Income - EUR | 123.094 | 108.639 | 62.195 | 63.463 | 60.927 | 91.216 | 76.272 | 64.527 | 79.767 | 74.102 |
| Total Expenses - EUR | 100.977 | 89.141 | 51.485 | 51.612 | 45.204 | 72.978 | 65.293 | 57.515 | 66.373 | 62.851 |
| Gross Profit/Loss - EUR | 22.117 | 19.498 | 10.710 | 11.852 | 15.723 | 18.237 | 10.980 | 7.011 | 13.394 | 11.251 |
| Net Profit/Loss - EUR | 18.626 | 16.579 | 9.284 | 10.036 | 14.260 | 15.997 | 9.171 | 5.457 | 11.658 | 9.683 |
| Employees | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vitasal Technomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.031 | 3.015 | 2.052 | 1.119 | 978 | 268 | 8 | 0 | 0 | 0 |
| Current Assets | 31.495 | 24.648 | 23.167 | 31.540 | 37.220 | 57.062 | 44.223 | 21.135 | 32.449 | 24.283 |
| Inventories | 4.667 | 6.506 | 4.512 | 5.921 | 5.380 | 9.619 | 9.190 | 7.080 | 8.423 | 9.569 |
| Receivables | 2.243 | 5.010 | 2.600 | 824 | 1.570 | 1.699 | 1.567 | 1.119 | 1.693 | 1.513 |
| Cash | 24.586 | 13.132 | 16.055 | 24.794 | 30.271 | 45.744 | 33.466 | 12.937 | 22.333 | 13.201 |
| Shareholders Funds | 21.600 | 19.522 | 19.016 | 28.703 | 33.470 | 48.832 | 39.897 | 15.595 | 27.205 | 19.734 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 10.978 | 8.203 | 6.204 | 3.956 | 4.729 | 8.497 | 4.334 | 5.540 | 5.255 | 4.565 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Vitasal Technomed Srl